{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:38:58Z","timestamp":1779262738896,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The influence of new SARS-CoV-2 variants on the post-COVID-19 condition (PCC) remains unanswered. Therefore, we examined the prevalence and predictors of PCC-related symptoms in patients infected with the SARS-CoV-2 variants delta or omicron.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared prevalences and risk factors of acute and PCC-related symptoms three months after primary infection (3MFU) between delta- and omicron-infected patients from the Cross-Sectoral Platform of the German National Pandemic Cohort Network. Health-related quality of life (HrQoL) was determined by the EQ-5D-5L index score and trend groups were calculated to describe changes of HrQoL between different time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We considered 758 patients for our analysis (delta: n\u2009=\u2009341; omicron: n\u2009=\u2009417). Compared with omicron patients, delta patients had a similar prevalence of PCC at the 3MFU (p\u2009=\u20090.354), whereby fatigue occurred most frequently (n\u2009=\u2009256, 34%). HrQoL was comparable between the groups with the lowest EQ-5D-5L index score (0.75, 95% CI\u00a00.73\u20130.78) at disease onset. While most patients (69%, n\u2009=\u2009348) never showed a declined HrQoL, it deteriorated substantially in 37 patients (7%) from the acute phase to the 3MFU of which 27 were infected with omicron.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>With quality-controlled data from a multicenter cohort, we showed that PCC is an equally common challenge for patients infected with the SARS-CoV-2 variants delta and omicron at least for the German population. Developing the EQ-5D-5L index score trend groups showed that over two thirds of patients did not experience any restrictions in their HrQoL due to or after the SARS-CoV-2 infection at the 3MFU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trail registration<\/jats:title>\n                    <jats:p>The cohort is registered at ClinicalTrials.gov since February 24, 2021 (Identifier: NCT04768998).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-024-02270-5","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T07:01:54Z","timestamp":1714719714000},"page":"2253-2267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron\u2014results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP)"],"prefix":"10.1007","volume":"52","author":[{"given":"Sina M.","family":"P\u00fctz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina S.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Miljukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marylyn M.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Bercker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Br\u00f6hl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"B\u00fcchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiwa","family":"Dashti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Erber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Friedrichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramsia","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"G\u00f6pel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Hanses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn-Erik Ole","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Keul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalbert","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Lorenz-Depiereux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Milovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazar","family":"Mitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"N\u00fcrnberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Obst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"R\u00f6mmele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimita","family":"Sikdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes Josef","family":"Tebbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil-Robin","family":"Tepasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Thelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Weismantel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Janne","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"2270_CR1","unstructured":"Public health England. investigation of novel SARS-COV-2 variant - variant of concern 202012\/01. 2020. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/959438\/Technical_Briefing_VOC_SH_NJL2_SH2.pdf. Accessed 2023-02-05."},{"key":"2270_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.21.21259268","author":"W Yang","year":"2021","unstructured":"Yang W, Shaman J. COVID-19 pandemic dynamics in India, the SARS-CoV-2 delta variant, and implications for vaccination. medRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.06.21.21259268.","journal-title":"medRxiv"},{"key":"2270_CR3","unstructured":"GISAID. Tracking of variants. 2021. https:\/\/gisaid.org\/hcov19-variants\/. Accessed 2023-02-05."},{"key":"2270_CR4","unstructured":"Robert Koch Institute. W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-(2019) (COVID-19): 05.08.2021\u2014aktualisierter Stand f\u00fcr Deutschland. 2021. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Wochenbericht\/Wochenbericht_2021-08-05.pdf?__blob=publicationFile. Accessed 5 Feb 2023."},{"key":"2270_CR5","unstructured":"Robert Koch Institute. W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19): 07.10.2021\u2013AKTUALISIERTER STAND F\u00dcR DEUTSCHLAND. (2021). https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Wochenbericht\/Wochenbericht_2021-10-07.pdf?__blob=publicationFile. Accessed 5 Feb 2023."},{"issue":"2","key":"2270_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41423-021-00836-z","volume":"19","author":"J Hu","year":"2022","unstructured":"Hu J, Peng P, Cao X, et al. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol Immunol. 2022;19:293\u20135. https:\/\/doi.org\/10.1038\/s41423-021-00836-z.","journal-title":"Cell Mol Immunol"},{"key":"2270_CR7","unstructured":"Robert Koch Institute. SARS-CoV-2 Varianten in Deutschland - Daten aus der integrierten genomischen Surveillance von SARS-CoV-2. (2023). https:\/\/public.data.rki.de\/t\/public\/views\/IGS_Dashboard\/DashboardVOC?%3Aembed=y&%3AisGuestRedirectFromVizportal=y."},{"key":"2270_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1412","author":"T Nyberg","year":"2021","unstructured":"Nyberg T, Twohig KA, Harris RJ, et al. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n1412.","journal-title":"BMJ"},{"issue":"11","key":"2270_CR9","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S1473-3099(21)00290-5","volume":"21","author":"P Bager","year":"2021","unstructured":"Bager P, Wohlfahrt J, Fonager J, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study. Lancet Infect Dis. 2021;21:1507\u201317. https:\/\/doi.org\/10.1016\/S1473-3099(21)00290-5.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2270_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","volume":"22","author":"KA Twohig","year":"2022","unstructured":"Twohig KA, Nyberg T, Zaidi A, et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2022;22:35\u201342. https:\/\/doi.org\/10.1016\/S1473-3099(21)00475-8.","journal-title":"Lancet Infect Dis"},{"key":"2270_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n579","author":"R Challen","year":"2021","unstructured":"Challen R, Brooks-Pollock E, Read JM, Dyson L, Tsaneva-Atanasova K, Danon L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012\/1: matched cohort study. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n579.","journal-title":"BMJ"},{"key":"2270_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03426-1","author":"NG Davies","year":"2021","unstructured":"Davies NG, Jarvis CI, Group CC-W, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-021-03426-1.","journal-title":"Nature"},{"issue":"1","key":"2270_CR13","doi-asserted-by":"publisher","first-page":"e1128","DOI":"10.1093\/cid\/ciab721","volume":"75","author":"SWX Ong","year":"2022","unstructured":"Ong SWX, Chiew CJ, Ang LW, et al. Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta). Clin Infect Dis. 2022;75:e1128\u201336. https:\/\/doi.org\/10.1093\/cid\/ciab721.","journal-title":"Clin Infect Dis"},{"key":"2270_CR14","unstructured":"WHO Regional Office for Africa. Omicron spreads but severe cases remain low in South Africa. (2021). https:\/\/www.afro.who.int\/news\/omicron-spreads-severe-cases-remain-low-south-africa. Accessed 2023-02-05."},{"issue":"10323","key":"2270_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(22)00017-4.","journal-title":"Lancet"},{"issue":"10335","key":"2270_CR16","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","volume":"399","author":"C Menni","year":"2022","unstructured":"Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399:1618\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(22)00327-0.","journal-title":"Lancet"},{"key":"2270_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijid.2022.11.024","volume":"127","author":"MA Davies","year":"2023","unstructured":"Davies MA, Morden E, Rousseau P, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province South Africa. Int J Infect Dis. 2023;127:63\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2022.11.024.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"2270_CR18","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/jmv.27613","volume":"94","author":"L Houhamdi","year":"2022","unstructured":"Houhamdi L, Gautret P, Hoang VT, Fournier PE, Colson P, Raoult D. Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021. J Med Virol. 2022;94:2290\u20135. https:\/\/doi.org\/10.1002\/jmv.27613.","journal-title":"J Med Virol"},{"issue":"21","key":"2270_CR19","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1001\/jama.2022.5575","volume":"327","author":"C Maslo","year":"2022","unstructured":"Maslo C, Toubkin M. Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave-Reply. JAMA. 2022;327:2148. https:\/\/doi.org\/10.1001\/jama.2022.5575.","journal-title":"JAMA"},{"key":"2270_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070695","author":"IL Ward","year":"2022","unstructured":"Ward IL, Bermingham C, Ayoubkhani D, et al. Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2) retrospective cohort study. BMJ. 2022. https:\/\/doi.org\/10.1136\/bmj-2022-070695.","journal-title":"BMJ"},{"issue":"3","key":"2270_CR21","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/cid\/ciac613","volume":"76","author":"KD Vihta","year":"2022","unstructured":"Vihta KD, Pouwels KB, Peto TE, et al. Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. Clin Infect Dis. 2022;76:e133\u201341. https:\/\/doi.org\/10.1093\/cid\/ciac613.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2270_CR22","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(21)00703-9.","journal-title":"Lancet Infect Dis"},{"key":"2270_CR23","unstructured":"World Health Organization (WHO). Post COVID-19 condition (Long COVID). 2023. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition. Accessed 2023-11-17."},{"key":"2270_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93\u2013135. https:\/\/doi.org\/10.1016\/j.bbi.2021.12.020.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"2270_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601\u201315. https:\/\/doi.org\/10.1038\/s41591-021-01283-z.","journal-title":"Nat Med"},{"key":"2270_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120162","author":"L Premraj","year":"2022","unstructured":"Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022. https:\/\/doi.org\/10.1016\/j.jns.2022.120162.","journal-title":"J Neurol Sci"},{"key":"2270_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.750378","author":"LD Hayes","year":"2021","unstructured":"Hayes LD, Ingram J, Sculthorpe NF. More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Front Med (Lausanne). 2021. https:\/\/doi.org\/10.3389\/fmed.2021.750378.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"2270_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226:1593\u2013607. https:\/\/doi.org\/10.1093\/infdis\/jiac136.","journal-title":"J Infect Dis"},{"key":"2270_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.16471","author":"E Rochmawati","year":"2022","unstructured":"Rochmawati E, Iskandar AC, Kamilah F. Persistent symptoms among post-COVID-19 survivors: A systematic review and meta-analysis. J Clin Nurs. 2022. https:\/\/doi.org\/10.1111\/jocn.16471.","journal-title":"J Clin Nurs"},{"key":"2270_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102562","author":"C Fernandez-de-Las-Penas","year":"2022","unstructured":"Fernandez-de-Las-Penas C, Nijs J, Neblett R, et al. Phenotyping Post-COVID Pain as a Nociceptive, Neuropathic, or Nociplastic Pain Condition. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10102562.","journal-title":"Biomedicines."},{"issue":"1","key":"2270_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12910-023-00959-0","volume":"24","author":"K Tilch","year":"2023","unstructured":"Tilch K, Hopff SM, Appel K, et al. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany. BMC Med Ethics. 2023;24:84. https:\/\/doi.org\/10.1186\/s12910-023-00959-0.","journal-title":"BMC Med Ethics"},{"key":"2270_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-022-00896-z","author":"M Schons","year":"2022","unstructured":"Schons M, Pilgram L, Reese J-P, et al. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur J Epidemiol. 2022. https:\/\/doi.org\/10.1007\/s10654-022-00896-z.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"2270_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","volume":"36","author":"K Ludwig","year":"2018","unstructured":"Ludwig K, von der Schulenburg JM, Greiner W. German Value Set for the EQ-5D-5L. Pharmacoeconomics. 2018;36:663\u201374. https:\/\/doi.org\/10.1007\/s40273-018-0615-8.","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"2270_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10198-019-01054-1","volume":"20","author":"T Grochtdreis","year":"2019","unstructured":"Grochtdreis T, Dams J, Konig HH, Konnopka A. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set. Eur J Health Econ. 2019;20:933\u201344. https:\/\/doi.org\/10.1007\/s10198-019-01054-1.","journal-title":"Eur J Health Econ"},{"key":"2270_CR35","unstructured":"RKI. W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19) 03.02.2022\u2014AKTUALISIERTER STAND F\u00dcR DEUTSCHLAND. (2022). https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Wochenbericht\/Wochenbericht_2022-02-03.pdf?__blob=publicationFile."},{"key":"2270_CR36","unstructured":"R Core Team. R: A language and environment for statistical computing, Vienna, Austria. (2021). https:\/\/www.R-project.org\/."},{"key":"2270_CR37","unstructured":"Kohls M, Miljukov O, N\u00fcrnberger C, Rainers M. epicodr: Primary coding for NAPKON data. (2023). https:\/\/github.com\/nukleus-ecu\/epicodr."},{"key":"2270_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/v14122629","author":"C Fernandez-de-Las-Penas","year":"2022","unstructured":"Fernandez-de-Las-Penas C, Notarte KI, Peligro PJ, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14122629.","journal-title":"Viruses"},{"issue":"8","key":"2270_CR39","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"WHO Working group on the clinical characterisation and management of COVID-19 infection","year":"2020","unstructured":"WHO Working group on the clinical characterisation and management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192\u20137.","journal-title":"Lancet Infect Dis"},{"key":"2270_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/v14112367","author":"M Spinicci","year":"2022","unstructured":"Spinicci M, Graziani L, Tilli M, et al. Infection with SARS-CoV-2 variants is associated with different long COVID phenotypes. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14112367.","journal-title":"Viruses"},{"key":"2270_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11070725","author":"C Fernandez-de-Las-Penas","year":"2022","unstructured":"Fernandez-de-Las-Penas C, Cancela-Cilleruelo I, Rodriguez-Jimenez J, et al. Associated-onset symptoms and post-COVID-19 symptoms in hospitalized COVID-19 survivors infected with wuhan, alpha or delta SARS-CoV-2 variant. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11070725.","journal-title":"Pathogens"},{"key":"2270_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081951","author":"C Fernandez-de-Las-Penas","year":"2022","unstructured":"Fernandez-de-Las-Penas C, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al. Prevalence of musculoskeletal post-COVID pain in hospitalized COVID-19 survivors depending on infection with the historical, alpha or delta SARS-CoV-2 variant. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10081951.","journal-title":"Biomedicines."},{"key":"2270_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2023.08.019","volume":"136","author":"S Diexer","year":"2023","unstructured":"Diexer S, Klee B, Gottschick C, et al. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. Int J Infect Dis. 2023;136:14\u201321. https:\/\/doi.org\/10.1016\/j.ijid.2023.08.019.","journal-title":"Int J Infect Dis"},{"key":"2270_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad382","author":"P Hedberg","year":"2023","unstructured":"Hedberg P, Naucler P. Post COVID-19 condition after SARS-CoV-2 infections during the omicron surge compared with the delta, alpha, and wild-type periods in Stockholm. Sweden J Infect Dis. 2023. https:\/\/doi.org\/10.1093\/infdis\/jiad382.","journal-title":"Sweden J Infect Dis"},{"key":"2270_CR45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44888","author":"RP Karyakarte","year":"2023","unstructured":"Karyakarte RP, Das R, Rajmane MV, et al. The burden and characteristics of Post-COVID-19 conditions among laboratory-confirmed delta and omicron COVID-19 cases: a preliminary study from Maharashtra, India. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.44888.","journal-title":"Cureus"},{"issue":"1","key":"2270_CR46","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12879-023-08787-8","volume":"23","author":"HN Thi Khanh","year":"2023","unstructured":"Thi Khanh HN, Cornelissen L, Castanares-Zapatero D, et al. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population. BMC Infect Dis. 2023;23:774. https:\/\/doi.org\/10.1186\/s12879-023-08787-8.","journal-title":"BMC Infect Dis"},{"issue":"10343","key":"2270_CR47","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","volume":"399","author":"M Antonelli","year":"2022","unstructured":"Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(22)00941-2.","journal-title":"Lancet"},{"key":"2270_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o1500","author":"J Wise","year":"2022","unstructured":"Wise J. Covid-19: Long covid risk is lower with omicron than delta, researchers find. BMJ. 2022. https:\/\/doi.org\/10.1136\/bmj.o1500.","journal-title":"BMJ"},{"key":"2270_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2023.104688","author":"A Hernandez-Aceituno","year":"2023","unstructured":"Hernandez-Aceituno A, Garcia-Hernandez A, Larumbe-Zabala E. COVID-19 long-term sequelae: omicron versus alpha and delta variants. Infect Dis Now. 2023. https:\/\/doi.org\/10.1016\/j.idnow.2023.104688.","journal-title":"Infect Dis Now"},{"issue":"4","key":"2270_CR50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/bjh.18700","volume":"201","author":"J Willan","year":"2023","unstructured":"Willan J, Agarwal G, Bienz N. Mortality and burden of post-COVID-19 syndrome have reduced with time across SARS-CoV-2 variants in haematology patients. Br J Haematol. 2023;201:640\u20134. https:\/\/doi.org\/10.1111\/bjh.18700.","journal-title":"Br J Haematol"},{"key":"2270_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281429","author":"T Ballouz","year":"2023","unstructured":"Ballouz T, Menges D, Kaufmann M, et al. Post COVID-19 condition after wildtype, delta, and omicron SARS-CoV-2 infection and prior vaccination: pooled analysis of two population-based cohorts. PLoS ONE. 2023. https:\/\/doi.org\/10.1371\/journal.pone.0281429.","journal-title":"PLoS ONE"},{"key":"2270_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192316010","author":"M Du","year":"2022","unstructured":"Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph192316010.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2270_CR53","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1038\/s41467-022-35240-2","volume":"13","author":"K Magnusson","year":"2022","unstructured":"Magnusson K, Kristoffersen DT, Dell\u2019Isola A, et al. Post-covid medical complaints following infection with SARS-CoV-2 omicron vs delta variants. Nat Commun. 2022;13:7363. https:\/\/doi.org\/10.1038\/s41467-022-35240-2.","journal-title":"Nat Commun"},{"key":"2270_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijid.2022.12.036","volume":"128","author":"W Jassat","year":"2023","unstructured":"Jassat W, Mudara C, Vika C, et al. A cohort study of post-COVID-19 condition across the beta, delta, and omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102\u201311. https:\/\/doi.org\/10.1016\/j.ijid.2022.12.036.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"2270_CR55","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/cid\/ciad045","volume":"76","author":"M Gottlieb","year":"2023","unstructured":"Gottlieb M, Wang RC, Yu H, et al. Severe fatigue and persistent symptoms at 3 months following severe acute respiratory syndrome coronavirus 2 infections during the pre-delta, delta, and omicron time periods: a multicenter prospective cohort study. Clin Infect Dis. 2023;76:1930\u201341. https:\/\/doi.org\/10.1093\/cid\/ciad045.","journal-title":"Clin Infect Dis"},{"key":"2270_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01190-4","author":"AR Percze","year":"2023","unstructured":"Percze AR, Nagy A, Polivka L, et al. Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms. Inflammopharmacology. 2023. https:\/\/doi.org\/10.1007\/s10787-023-01190-4.","journal-title":"Inflammopharmacology"},{"key":"2270_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.10.022","author":"J Agergaard","year":"2023","unstructured":"Agergaard J, Gunst JD, Schiottz-Christensen B, Ostergaard L, Wejse C. Long-term prognosis at 1.5 years after Infection with Wild-type strain of SARS-CoV-2 and alpha, delta, as well as omicron variants. Int J Infect Dis. 2023. https:\/\/doi.org\/10.1016\/j.ijid.2023.10.022.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"2270_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.healthpol.2015.11.005","volume":"120","author":"H Grupp","year":"2016","unstructured":"Grupp H, Konig HH, Konnopka A. Health care utilisation and costs in the general population in Germany. Health Policy. 2016;120:159\u201369. https:\/\/doi.org\/10.1016\/j.healthpol.2015.11.005.","journal-title":"Health Policy"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02270-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02270-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02270-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:13:14Z","timestamp":1770905594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02270-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2270"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02270-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3845618\/v1","asserted-by":"object"}]},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. For the NAPKON-SUEP, a primary ethics vote was obtained at the Ethics Committee of the Department of Medicine at Goethe University Frankfurt (local ethics ID approval 20-924). All further study sites received their local ethics votes at the respective ethics commissions. The NAPKON-SUEP is registered at ClinicalTrials.gov (Identifier: NCT04768998). Approval for this study was granted by the Ethics Committee of the Department of Medicine at Goethe University Frankfurt (local ethics ID approval 2021-350).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}